The abstract is read at the publisher; the summary is JClub's.
A 14-protein plasma signature predicts lung cancer years before diagnosis, enabling detection of tumor-promoting lung niches in advance of clinical presentation.
- Why it matters: Early lung tumorigenesis is shaped by tumor-promoting niches, but these microenvironments are hard to detect before cancer becomes apparent.
- What they did: Pandya et al. used a 14-protein plasma signature to predict lung cancer years prior to diagnosis and linked tumor-promoting niche biology to interleukin-1β–associated alveolar remodeling.
- The result: The findings suggest tumor promotion can be targeted for precision prevention by using plasma signals to reveal and guide intervention in lung niches.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.